JP2021534108A5 - - Google Patents

Info

Publication number
JP2021534108A5
JP2021534108A5 JP2021506683A JP2021506683A JP2021534108A5 JP 2021534108 A5 JP2021534108 A5 JP 2021534108A5 JP 2021506683 A JP2021506683 A JP 2021506683A JP 2021506683 A JP2021506683 A JP 2021506683A JP 2021534108 A5 JP2021534108 A5 JP 2021534108A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
independently selected
heterocyclyls
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021506683A
Other languages
English (en)
Japanese (ja)
Other versions
JP7651451B2 (ja
JP2021534108A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/045466 external-priority patent/WO2020033520A1/en
Publication of JP2021534108A publication Critical patent/JP2021534108A/ja
Publication of JP2021534108A5 publication Critical patent/JP2021534108A5/ja
Application granted granted Critical
Publication of JP7651451B2 publication Critical patent/JP7651451B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021506683A 2018-08-08 2019-08-07 Pad酵素のインドールおよびアザインドール阻害剤 Active JP7651451B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862715850P 2018-08-08 2018-08-08
US62/715,850 2018-08-08
PCT/US2019/045466 WO2020033520A1 (en) 2018-08-08 2019-08-07 Indole and azaindole inhibitors of pad enzymes

Publications (3)

Publication Number Publication Date
JP2021534108A JP2021534108A (ja) 2021-12-09
JP2021534108A5 true JP2021534108A5 (cg-RX-API-DMAC7.html) 2022-08-16
JP7651451B2 JP7651451B2 (ja) 2025-03-26

Family

ID=67766306

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021506683A Active JP7651451B2 (ja) 2018-08-08 2019-08-07 Pad酵素のインドールおよびアザインドール阻害剤

Country Status (18)

Country Link
US (1) US11524959B1 (cg-RX-API-DMAC7.html)
EP (1) EP3833440A1 (cg-RX-API-DMAC7.html)
JP (1) JP7651451B2 (cg-RX-API-DMAC7.html)
KR (1) KR102885181B1 (cg-RX-API-DMAC7.html)
CN (1) CN112805067B (cg-RX-API-DMAC7.html)
AR (1) AR115920A1 (cg-RX-API-DMAC7.html)
AU (1) AU2019319835A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021002091A2 (cg-RX-API-DMAC7.html)
CA (1) CA3108791A1 (cg-RX-API-DMAC7.html)
CL (1) CL2021000296A1 (cg-RX-API-DMAC7.html)
CO (1) CO2021001217A2 (cg-RX-API-DMAC7.html)
EA (1) EA202190462A1 (cg-RX-API-DMAC7.html)
IL (1) IL280650A (cg-RX-API-DMAC7.html)
MX (1) MX2021001565A (cg-RX-API-DMAC7.html)
PE (1) PE20211068A1 (cg-RX-API-DMAC7.html)
SG (1) SG11202101174RA (cg-RX-API-DMAC7.html)
TW (1) TW202019415A (cg-RX-API-DMAC7.html)
WO (1) WO2020033520A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3833440A1 (en) 2018-08-08 2021-06-16 Bristol-Myers Squibb Company Indole and azaindole inhibitors of pad enzymes
ES2956090T3 (es) 2018-08-08 2023-12-13 Bristol Myers Squibb Co Inhibidores de bencimidazol de enzimas PAD
ES2929200T3 (es) 2018-08-08 2022-11-25 Bristol Myers Squibb Co Tienopirroles sustituidos como inhibidores de PAD4
CN115298175B (zh) 2020-02-06 2024-05-07 百时美施贵宝公司 可用作免疫抑制剂的大环pad4抑制剂
TW202140477A (zh) 2020-02-12 2021-11-01 美商必治妥美雅史谷比公司 雜環pad4抑制劑
MX2022013615A (es) 2020-04-30 2022-11-16 Gilead Sciences Inc Inhibidores de macrociclo de peptidilarginina deiminasas.
CN111943947B (zh) * 2020-07-24 2021-04-30 重庆文理学院 1H-吡咯[2,3-b]吡啶衍生物及其合成方法与应用
WO2022040267A1 (en) 2020-08-19 2022-02-24 Bristol-Myers Squibb Company 1h-pyrrolo[3,2-c]pyridine and 1h-pyrrolo[2,3-c]pyridine derivatives as tlr9 inhibitors for the treatment of fibrosis
US12492188B2 (en) 2020-08-19 2025-12-09 Bristol-Myers Squibb Company 1H-benzo[D]imidazole derivatives as TLR9 inhibitors for the treatment of fibrosis
EP4267562A1 (en) * 2020-12-22 2023-11-01 Gilead Sciences, Inc. Inhibitors of peptidylarginine deiminases
TW202233174A (zh) * 2020-12-22 2022-09-01 美商基利科學股份有限公司 肽基精胺酸去亞胺酶之抑制劑
WO2025024265A1 (en) 2023-07-21 2025-01-30 Bristol-Myers Squibb Company Methods of assessing citrullination and activity of pad4 modulators
CN117427074B (zh) * 2023-11-13 2026-07-28 山东第一医科大学(山东省医学科学院) 四氢喹啉醇作为铁死亡抑制剂在制备急性肾损伤药物中的应用
WO2026020127A2 (en) 2024-07-19 2026-01-22 Bristol-Myers Squibb Company Methods of assessing citrullination and activity of pad2 modulators

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2611010C2 (ru) 2012-07-26 2017-02-17 Глаксо Груп Лимитед 2-(Азаиндол-2-ил)бензимидазолы в качестве ингибиторов PAD4
WO2016185279A1 (en) 2015-05-21 2016-11-24 Glaxosmithkline Intellectual Property Development Limited Benzoimidazole derivatives as pad4 inhibitors
AR107032A1 (es) * 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores bicíclicos de pad4
AR107030A1 (es) 2015-12-09 2018-03-14 Padlock Therapeutics Inc Inhibidores aza-bencimidazol de pad4
CN108602812B (zh) 2015-12-22 2021-11-02 坎塞拉有限公司 可用作哺乳动物组蛋白去乙酰化酶活性的抑制剂的双环异羟肟酸类化合物
SG11201807021UA (en) 2016-02-23 2018-09-27 Padlock Therapeutics Inc Heteroaryl inhibitors of pad4
US10703741B2 (en) 2016-07-27 2020-07-07 Padlock Therapeutics, Inc. Covalent inhibitors of PAD4
KR102502992B1 (ko) 2016-09-12 2023-02-24 패들락 테라퓨틱스, 인코포레이티드 Pad4의 헤테로아릴 억제제
JP7311228B2 (ja) 2017-06-30 2023-07-19 ベイジン タイド ファーマシューティカル カンパニー リミテッド Rho-関連プロテインキナーゼ阻害剤、それを含む医薬組成物並びにその調製方法及び使用
CN111225915B (zh) 2017-10-18 2023-03-07 朱比兰特埃皮帕德有限公司 作为pad抑制剂的咪唑并吡啶化合物
MX2021001471A (es) 2018-08-08 2021-04-28 Bristol Myers Squibb Co Benzimidazoles sustituidos como inhibidores de peptidil arginina deiminasa 4 (pad4).
ES2929200T3 (es) 2018-08-08 2022-11-25 Bristol Myers Squibb Co Tienopirroles sustituidos como inhibidores de PAD4
EP3833440A1 (en) 2018-08-08 2021-06-16 Bristol-Myers Squibb Company Indole and azaindole inhibitors of pad enzymes
ES2956090T3 (es) 2018-08-08 2023-12-13 Bristol Myers Squibb Co Inhibidores de bencimidazol de enzimas PAD

Similar Documents

Publication Publication Date Title
JP2024543976A5 (cg-RX-API-DMAC7.html)
JP2021534097A5 (cg-RX-API-DMAC7.html)
JP2021534104A5 (cg-RX-API-DMAC7.html)
JP2021515010A5 (cg-RX-API-DMAC7.html)
JP2023512557A5 (cg-RX-API-DMAC7.html)
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP2007505933A5 (cg-RX-API-DMAC7.html)
JP2008535903A5 (cg-RX-API-DMAC7.html)
JP2008535902A5 (cg-RX-API-DMAC7.html)
JP2020505376A5 (cg-RX-API-DMAC7.html)
JP2017526675A5 (cg-RX-API-DMAC7.html)
JP2013538230A5 (cg-RX-API-DMAC7.html)
JP2017537940A5 (cg-RX-API-DMAC7.html)
JP2009504764A5 (cg-RX-API-DMAC7.html)
JP2015529235A5 (cg-RX-API-DMAC7.html)
RU2015122757A (ru) Бициклические соединения мочевины, тиомочевины, гуанидина и цианогуанидина, пригодные для лечения боли
RU2008152763A (ru) Применение агонистов каннабиноидного рецептора в качестве индуцирующих гипотермию лекарственных средств для лечения ишемии
RU2005107314A (ru) Пиримидопроизводные, характеризующиеся антипролиферативной активностью
JP2009535307A5 (cg-RX-API-DMAC7.html)
JP2016534134A5 (cg-RX-API-DMAC7.html)
JP2014531434A5 (cg-RX-API-DMAC7.html)
JP2017519754A5 (cg-RX-API-DMAC7.html)
JP2012517444A5 (cg-RX-API-DMAC7.html)
RU2004109812A (ru) Ингибиторы цистеинпротеазы 2-циано-4-аминопиримидинового строения с ингибирующим действием на катепсин к для лечения воспалительных и других заболеваний
JP2019500387A5 (cg-RX-API-DMAC7.html)